speb/financial-data huggingface dataset:
Financial ratios for CEC.DE — annual report dated 2024-09-30
Total revenue: 24935555555.555553
Gross profit: 4401111111.111111
Operating income: 254444444.44444445
Net income: 85555555.55555555
Capital expenditures: 214444444.44444445
Operating cash flow: 931111111.111111
Depreciation & amortization: 735555555.5555556
Net tangible assets: -214444444.44444445
Owner earnings: 606666666.6666667
Return on net tangible assets (%): -282.9015544041451
Capex to operating income (%): 84.27947598253274
Buffett classification: The Gruesome
Stock price: 3.622222222222222
P/E ratio: 20.543126413506492
Shares outstanding: 485221084
Book value: 572222222.2222214
P/B ratio: 3.071496570563111
Market cap (USD): 1757578593.1555552
Debt to equity: 5.1087378640776775
Current ratio: 0.9127545248868778
Quick ratio: 0.47242647058823534
Effective tax rate (%): 12.5
Interest coverage ratio: 0.9271255060728746
COGS to revenue (%): 82.35005792710098
SG&A to revenue (%): 9.531236075216112
Free cash flow (dilution-adjusted): 716666666.6666666
Buyback yield (%): 0
Retained earnings: -1236666666.6666667
Inventory turnover: 5.934810533076429
Receivables turnover: 14.832782551222735
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.476330395037547
FCF margin (%): 2.87407539434988
Revenue growth (%): 6.5047108073814215
Rule of 40 score: 9.378786201731302
Financial ratios for CEC.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.622222222222222
Shares outstanding: 485221084
Market cap (USD): 1757578593.1555552
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEC.DE — quarterly report dated 2024-12-31
Total revenue: 7885416666.666667
Gross profit: 1334375000
Operating income: 248958333.33333334
Net income: 154166666.6666667
Capital expenditures: 63541666.66666667
Operating cash flow: 1755208333.3333335
Depreciation & amortization: 202083333.33333334
Net tangible assets: -27083333.333333336
Owner earnings: 292708333.3333333
Return on net tangible assets (%): -1080.7692307692307
Capex to operating income (%): 25.523012552301257
Buffett classification: The Good
Stock price: 2.7395833333333335
P/E ratio: 2.155627450878378
Shares outstanding: 485221084
Book value: 693750000
P/B ratio: 1.9161132896696698
Market cap (USD): 1329303594.7083335
Debt to equity: 3.891891891891892
Current ratio: 0.9541136042045685
Quick ratio: 0.5807560137457045
Effective tax rate (%): 13.953488372093023
Interest coverage ratio: 3.6212121212121215
COGS to revenue (%): 83.0779392338177
SG&A to revenue (%): 14.425363276089827
Free cash flow (dilution-adjusted): 1691666666.6666667
Buyback yield (%): 0
Retained earnings: -1002083333.3333334
Inventory turnover: 1.702490525175961
Receivables turnover: 2.912658714890342
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.457098283931354
FCF margin (%): 21.453104359313077
Rule of 40 score: 21.453104359313077
Financial ratios for CEC.DE — quarterly report dated 2025-03-31
Total revenue: 5709782608.695652
Gross profit: 1045652173.9130434
Operating income: 1086956.5217391304
Net income: -35869565.217391305
Capital expenditures: 48913043.47826087
Operating cash flow: -1619565217.3913043
Depreciation & amortization: 183695652.17391303
Net tangible assets: -68478260.86956522
Owner earnings: 98913043.47826084
Capex to operating income (%): 4500
Buffett classification: The Gruesome
Stock price: 3.6086956521739126
Shares outstanding: 485221084
Book value: 689130434.782608
P/B ratio: 2.540905361009466
Market cap (USD): 1751015216.1739128
Debt to equity: 4.044164037854894
Current ratio: 0.9264371087080251
Quick ratio: 0.45702902675014234
Interest coverage ratio: 0.01694915254237288
COGS to revenue (%): 81.6866552446221
SG&A to revenue (%): 15.876641918903484
Free cash flow (dilution-adjusted): -1668478260.8695652
Buyback yield (%): 0
Retained earnings: -1080434782.6086955
Inventory turnover: 1.3006971809639283
Receivables turnover: 3.015499425947187
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.03266906239790918
FCF margin (%): -29.22139729678279
Revenue growth (%): -27.59060364137615
Rule of 40 score: -56.81200093815894
Financial ratios for CEC.DE — quarterly report dated 2025-06-30
Total revenue: 5650588235.294118
Gross profit: 1007058823.5294118
Operating income: -65882352.941176474
Net income: -134117647.05882353
Capital expenditures: 44705882.35294118
Operating cash flow: 292941176.47058827
Depreciation & amortization: 198823529.4117647
Net tangible assets: -212941176.47058824
Owner earnings: 20000000.000000007
Buffett classification: The Gruesome
Stock price: 4.258823529411765
Shares outstanding: 485221084
Book value: 610588235.294117
P/B ratio: 3.3843936880154177
Market cap (USD): 2066470969.5058823
Debt to equity: 4.969171483622357
Current ratio: 0.9201137171286425
Quick ratio: 0.4764747690120825
Interest coverage ratio: -1.0769230769230769
COGS to revenue (%): 82.17780553820529
SG&A to revenue (%): 19.820945242556736
Free cash flow (dilution-adjusted): 248235294.11764705
Buyback yield (%): 0
Retained earnings: -1304705882.3529413
Inventory turnover: 1.2646587632169177
Receivables turnover: 2.773094688221709
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9263845889232887
FCF margin (%): 4.393087653549864
Revenue growth (%): -1.0367185137904311
Rule of 40 score: 3.3563691397594333
Financial ratios for CEC.DE — annual report dated 2025-09-30
Total revenue: 27143529411.764706
Gross profit: 4887058823.529412
Operating income: 324705882.35294116
Net income: -40000000
Capital expenditures: 223529411.7647059
Operating cash flow: 1235294117.647059
Depreciation & amortization: 824705882.3529412
Net tangible assets: -263529411.7647059
Owner earnings: 561176470.5882353
Capex to operating income (%): 68.84057971014494
Buffett classification: The Good
Stock price: 5.164705882352941
Shares outstanding: 485221084
Book value: 570588235.2941189
P/B ratio: 4.392001152082464
Market cap (USD): 2506024186.77647
Debt to equity: 5.228865979381433
Current ratio: 0.8976537216828478
Quick ratio: 0.4648058252427184
Effective tax rate (%): 221.42857142857144
Interest coverage ratio: 1.1452282157676348
COGS to revenue (%): 81.99549237170596
SG&A to revenue (%): 9.565707350901526
Free cash flow (dilution-adjusted): 1011764705.882353
Buyback yield (%): 0
Retained earnings: -1081176470.5882354
Inventory turnover: 5.893457943925234
Receivables turnover: 15.269358041032428
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.956709956709954
FCF margin (%): 3.7274618585298196
Revenue growth (%): 8.854720927672387
Rule of 40 score: 12.582182786202207
Financial ratios for CEC.DE — quarterly report dated 2025-09-30
Total revenue: 6415294117.647059
Gross profit: 1249411764.7058823
Operating income: 118823529.41176471
Net income: -35294117.64705882
Capital expenditures: 54117647.05882353
Operating cash flow: 712941176.4705882
Depreciation & amortization: 198823529.4117647
Net tangible assets: -263529411.7647059
Owner earnings: 109411764.70588237
Capex to operating income (%): 45.54455445544555
Buffett classification: The Good
Stock price: 5.164705882352941
Shares outstanding: 485221084
Book value: 570588235.2941189
P/B ratio: 4.392001152082464
Market cap (USD): 2506024186.77647
Debt to equity: 5.228865979381433
Current ratio: 0.8976537216828478
Quick ratio: 0.4648058252427184
Effective tax rate (%): 225
Interest coverage ratio: 1.578125
COGS to revenue (%): 80.52448193654868
SG&A to revenue (%): -2.0355767467449106
Free cash flow (dilution-adjusted): 658823529.4117647
Buyback yield (%): 0
Retained earnings: -1081176470.5882354
Inventory turnover: 1.3679127725856697
Receivables turnover: 3.608868299139643
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6435786435786435
FCF margin (%): 10.269576379974325
Revenue growth (%): 13.533208411409541
Rule of 40 score: 23.802784791383864
Financial ratios for CEC.DE — quarterly report dated 2025-12-31
Total revenue: 8948235294.117647
Gross profit: 1548235294.1176472
Operating income: 342352941.1764706
Net income: 212941176.47058824
Capital expenditures: 55294117.64705882
Operating cash flow: 1861176470.5882354
Depreciation & amortization: 198823529.4117647
Net tangible assets: -48235294.11764706
Owner earnings: 356470588.2352941
Return on net tangible assets (%): -739.0243902439024
Capex to operating income (%): 16.151202749140893
Buffett classification: The Great
Stock price: 5.188235294117647
P/E ratio: 328.6542540909513
Shares outstanding: 485221084
Book value: 787058823.5294113
P/B ratio: 3.198542571659195
Market cap (USD): 2517441153.4588237
Debt to equity: 3.844544095665174
Current ratio: 0.9449254933548128
Quick ratio: 0.5679621425694724
Effective tax rate (%): 24.583333333333336
Interest coverage ratio: 4.546874999999999
COGS to revenue (%): 82.69787010255062
SG&A to revenue (%): 14.120431238495923
Free cash flow (dilution-adjusted): 1805882352.9411764
Buyback yield (%): 0
Retained earnings: -864705882.3529412
Inventory turnover: 1.6800213675213673
Receivables turnover: 3.033905065815716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.81450252951096
FCF margin (%): 20.181435708651062
Revenue growth (%): 39.48285347515128
Rule of 40 score: 59.66428918380234
Financial ratios for CG1.AX — annual report dated 2021-06-30
Total revenue: 9170791.729323307
Gross profit: 2452387.9699248117
Operating income: -4444618.796992481
Net income: -4009662.4060150376
Capital expenditures: 178592.4812030075
Depreciation & amortization: 1273515.037593985
Net tangible assets: 2651212.030075188
Owner earnings: -2914739.84962406
Return on net tangible assets (%): -109.93989981032935
Buffett classification: The Gruesome
Stock price: 0.09774436090225563
Shares outstanding: 433330377
Book value: 6299705.263157895
P/B ratio: 6.723425777885777
Market cap (USD): 42355600.75939849
Debt to equity: 0.8824157903078887
Current ratio: 0.5780151269787214
Quick ratio: 0.3811869986228055
Interest coverage ratio: -6.602477097625212
COGS to revenue (%): 73.2587104548086
SG&A to revenue (%): 48.98915345244911
Free cash flow (dilution-adjusted): -3101283.4586466164
Buyback yield (%): 0.9799593483060938
Retained earnings: -62795181.95488721
Inventory turnover: 5.43802654296907
Receivables turnover: 10.014263804436533
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -55.52966221305976
FCF margin (%): -33.81696531969387
Rule of 40 score: -33.81696531969387
Financial ratios for CG1.AX — annual report dated 2022-06-30
Total revenue: 12639343.448275862
Gross profit: 4262433.103448276
Operating income: -2680031.724137931
Net income: -3074831.0344827585
Capital expenditures: 559887.5862068966
Depreciation & amortization: 1474855.1724137932
Net tangible assets: 3975457.931034483
Owner earnings: -2159863.448275862
Return on net tangible assets (%): -54.329928419436904
Buffett classification: The Gruesome
Stock price: 0.11724137931034484
Shares outstanding: 433330377
Book value: 7671470.344827586
P/B ratio: 6.622492014298928
Market cap (USD): 50804251.09655173
Debt to equity: 0.6740756975779134
Current ratio: 0.6471382741905338
Quick ratio: 0.3396783031377763
Interest coverage ratio: -4.338862731218116
COGS to revenue (%): 66.27646743763644
SG&A to revenue (%): 35.428880854134285
Free cash flow (dilution-adjusted): -2376974.4827586208
Buyback yield (%): 0.7832510449370947
Retained earnings: -60673170.344827585
Inventory turnover: 3.890292428827287
Receivables turnover: 8.979432171339287
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -31.753084531332142
FCF margin (%): -18.806154706420806
Revenue growth (%): 37.82172598971989
Rule of 40 score: 19.01557128329908
Financial ratios for CG1.AX — annual report dated 2023-06-30
Total revenue: 10221067.549668875
Gross profit: 3013999.3377483445
Operating income: -3573762.913907285
Net income: -3962762.251655629
Capital expenditures: 271552.3178807947
Depreciation & amortization: 1618829.1390728478
Net tangible assets: 6957384.768211921
Owner earnings: -2615485.430463576
Return on net tangible assets (%): -37.592939266686095
Buffett classification: The Gruesome
Stock price: 0.046357615894039736
Shares outstanding: 433330377
Book value: 10779212.582781456
P/B ratio: 1.8636020968984268
Market cap (USD): 20088163.172185432
Debt to equity: 0.7111847177523626
Current ratio: 0.6532373839376827
Quick ratio: 0.4196227925658771
Interest coverage ratio: -4.981148481438781
COGS to revenue (%): 70.51189297887002
SG&A to revenue (%): 41.753832429732846
Free cash flow (dilution-adjusted): -2412668.2119205296
Buyback yield (%): 1.5593677813439524
Retained earnings: -62225078.145695366
Inventory turnover: 3.2922855707157783
Receivables turnover: 10.829932068258735
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.459426684093724
FCF margin (%): -23.60485536560896
Revenue growth (%): -19.132923387225983
Rule of 40 score: -42.73777875283494
Financial ratios for CHAMBLFERT.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.102070420677832
Shares outstanding: 400652297
Market cap (USD): 2044156233.5003295
Buyback yield (%): 0
Retained earnings: 732524066.9919558
Capitalized R&D asset: 443096.3998417513
Rule of 40 score: 0
Financial ratios for CHAMBLFERT.NS — annual report dated 2023-03-31
Total revenue: 3382637028.0146165
Gross profit: 960894031.6686968
Operating income: 193856272.83800244
Net income: 125970767.35688186
Capital expenditures: 23512789.28136419
Operating cash flow: 394550548.1120585
Depreciation & amortization: 37550548.11205847
Net tangible assets: 860626065.773447
Owner earnings: 140008526.18757612
Return on net tangible assets (%): 16.26821819087597
Capex to operating income (%): 12.128980371459448
Buffett classification: The Great
Stock price: 3.0192448233861144
P/E ratio: 9.602762601802324
Shares outstanding: 400652297
Book value: 859064555.4202192
P/B ratio: 1.4081216202701858
Market cap (USD): 1209667373.6950061
Debt to equity: 0.476171571490957
Current ratio: 1.7888609008483125
Quick ratio: 1.3530204876686946
Effective tax rate (%): 27.009242196380782
Interest coverage ratio: 5.47793763337234
COGS to revenue (%): 71.5933449639828
R&D to revenue (%): 0.012386821717987358
SG&A to revenue (%): 0.19793709006911772
Free cash flow (dilution-adjusted): 370465286.23629725
Buyback yield (%): 0
Retained earnings: 758254567.6004872
Inventory turnover: 14.472321903001097
Receivables turnover: 15.774930700717986
Capitalized R&D asset: 715875.80592077
ROCI (R&D-adjusted, %): 16.548967262733008
FCF margin (%): 10.951966858050264
Rule of 40 score: 10.951966858050264
Financial ratios for CHAMBLFERT.NS — annual report dated 2024-03-31
Total revenue: 2152252068.5933566
Gross profit: 824573689.8908741
Operating income: 210214654.03525603
Net income: 152991965.46348482
Capital expenditures: 72791701.64288284
Operating cash flow: 398938721.6692649
Depreciation & amortization: 37509293.6802974
Net tangible assets: 871816764.6000719
Owner earnings: 117709557.50089939
Return on net tangible assets (%): 13.501639596813241
Capex to operating income (%): 34.627320334516085
Buffett classification: The Good
Stock price: 3.954774472168906
P/E ratio: 10.3566842323469
Shares outstanding: 400652297
Book value: 870375344.7655593
P/B ratio: 1.8204668663014878
Market cap (USD): 1584489476.391435
Debt to equity: 0.25818607176022246
Current ratio: 2.0078317187062686
Quick ratio: 1.39177252171522
Effective tax rate (%): 32.39197023815832
Interest coverage ratio: 10.89958341105515
COGS to revenue (%): 61.687866308810676
R&D to revenue (%): 0.018553981779209843
SG&A to revenue (%): 0.3414935565308622
Free cash flow (dilution-adjusted): 325452692.1693249
Buyback yield (%): 6.545267694883518
Retained earnings: 758893152.6561937
Inventory turnover: 8.824310968708653
Receivables turnover: 93.6919503027772
Capitalized R&D asset: 826281.0846752102
ROCI (R&D-adjusted, %): 18.49091322219096
Rosenberg metric: -325.34593197555915
FCF margin (%): 15.121495150056024
Revenue growth (%): -36.3735437539219
Rule of 40 score: -21.252048603865877
Financial ratios for CHAMBLFERT.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 979500716.6746297
Buffett classification: The Gruesome
Stock price: 6.131032011466794
Shares outstanding: 400652297
Book value: 978069756.330626
P/B ratio: 2.5114896381115965
Market cap (USD): 2456412058.3747015
Debt to equity: 0.012145229837330856
Current ratio: 1.7138290221232693
Quick ratio: 1.2678020227185913
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHAMBLFERT.NS — quarterly report dated 2024-12-31
Total revenue: 573267280.5688308
Gross profit: 230228464.85604382
Operating income: 81000116.56370206
Net income: 62293973.65660333
Capital expenditures: 0
Depreciation & amortization: 9678284.182305628
Owner earnings: 71972257.83890896
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.64273225317636
P/E ratio: 9.07300299646018
Shares outstanding: 400652297
Market cap (USD): 2260773638.5910945
Effective tax rate (%): 31.707815774676686
Interest coverage ratio: 100.12968299711817
COGS to revenue (%): 59.83924555617459
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHAMBLFERT.NS — annual report dated 2025-03-31
Total revenue: 1946013560.9071777
Gross profit: 856920738.8356324
Operating income: 251732522.79635257
Net income: 192834931.02642038
Capital expenditures: 66529109.18868365
Operating cash flow: 162953004.44236612
Depreciation & amortization: 38595978.48959551
Net tangible assets: 1019935702.595277
Owner earnings: 164901800.32733223
Return on net tangible assets (%): 16.167862337570046
Capex to operating income (%): 26.42849181728679
Buffett classification: The Good
Stock price: 7.153926945968024
P/E ratio: 14.863682882639035
Shares outstanding: 400652297
Book value: 1018469721.7675941
P/B ratio: 2.814258688513407
Market cap (USD): 2866237263.472284
Debt to equity: 0.011336101166323652
Current ratio: 3.0848883854428384
Quick ratio: 1.5498880021803374
Effective tax rate (%): 32.72491444746727
Interest coverage ratio: 44.47170590665015
COGS to revenue (%): 55.96532541961528
R&D to revenue (%): 0.020425082000696856
SG&A to revenue (%): 0.3218752628227463
Free cash flow (dilution-adjusted): 95966799.15828851
Buyback yield (%): 0
Retained earnings: 895153144.7276127
Inventory turnover: 5.169034949980302
Receivables turnover: 45.24407479886932
Capitalized R&D asset: 803295.3334639653
ROCI (R&D-adjusted, %): 21.028991245094332
Rosenberg metric: 81.00361596106289
FCF margin (%): 4.931455827756484
Revenue growth (%): -9.582451363188598
Rule of 40 score: -4.650995535432114
Financial ratios for CHAMBLFERT.NS — quarterly report dated 2025-03-31
Total revenue: 286267243.39490294
Gross profit: 146463642.7402385
Operating income: 9555763.385550618
Net income: 15239653.963058216
Capital expenditures: 0
Depreciation & amortization: 9541734.860883797
Net tangible assets: 1019935702.595277
Owner earnings: 24781388.823942013
Return on net tangible assets (%): 2.4297010841844777
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.153926945968024
P/E ratio: 47.01939542755047
Shares outstanding: 400652297
Book value: 1018469721.7675941
P/B ratio: 2.814258688513407
Market cap (USD): 2866237263.472284
Debt to equity: 0.011336101166323652
Current ratio: 3.0848883854428384
Quick ratio: 1.5498880021803374
Effective tax rate (%): 22.30503219651801
COGS to revenue (%): 48.836743944820384
Buyback yield (%): 0
Retained earnings: 895153144.7276127
Inventory turnover: 0.6635336155668622
Receivables turnover: 6.655604479234616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7988210207005466
Revenue growth (%): -50.06391379761791
Rule of 40 score: -50.06391379761791
Financial ratios for CHAMBLFERT.NS — quarterly report dated 2025-06-30
Total revenue: 666699040.4867775
Gross profit: 233962087.52632812
Operating income: 79161010.99929792
Net income: 64235899.83618067
Capital expenditures: 0
Depreciation & amortization: 9882986.1923707
Owner earnings: 74118886.02855137
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.482213901240347
P/E ratio: 18.31926744614575
Shares outstanding: 400652297
Market cap (USD): 2597113889.177276
Effective tax rate (%): 27.156545280815376
Interest coverage ratio: 278.39917695473247
COGS to revenue (%): 64.90739099376755
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 132.89393245984226
Rule of 40 score: 132.89393245984226
Financial ratios for CHAMBLFERT.NS — quarterly report dated 2025-12-31
Total revenue: 657041327.8378078
Gross profit: 233397571.5717946
Operating income: 81648657.68073967
Net income: 65323604.76773978
Capital expenditures: 0
Depreciation & amortization: 9778322.37941406
Owner earnings: 75101927.14715384
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.37039099922023
P/E ratio: 10.38981576319361
Shares outstanding: 400652297
Market cap (USD): 2151659489.62571
Effective tax rate (%): 23.6511119212541
Interest coverage ratio: 796.6956521739131
COGS to revenue (%): 64.47748997161874
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.4485865529247461
Rule of 40 score: -1.4485865529247461
Financial ratios for CMI.V — annual report dated 2021-11-30
Capital expenditures: 3749.6062992125985
Buffett classification: The Gruesome
Stock price: 1.7480314960629924
Shares outstanding: 42256500
Market cap (USD): 73865692.91338584
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMI.V — annual report dated 2022-11-30
Total revenue: 8563922.05882353
Gross profit: 4285313.235294118
Operating income: 1038042.6470588235
Net income: 837981.6176470588
Capital expenditures: 29311.029411764703
Operating cash flow: 2299280.147058823
Depreciation & amortization: 18772.05882352941
Net tangible assets: 18542177.94117647
Owner earnings: 827442.6470588235
Return on net tangible assets (%): 4.4624889788234
Capex to operating income (%): 2.8236825813288298
Buffett classification: The Great
Stock price: 1.0955882352941175
P/E ratio: 55.24670624004632
Shares outstanding: 42256500
Book value: 18542972.79411765
P/B ratio: 2.4966721775805105
Market cap (USD): 46295724.264705874
Debt to equity: 0
Current ratio: 23.54357588420408
Quick ratio: 17.572907899870337
Effective tax rate (%): 38.963871204773405
COGS to revenue (%): 49.96085665120107
R&D to revenue (%): 7.8287212754876085
SG&A to revenue (%): 30.089309340981927
Free cash flow (dilution-adjusted): 1837444.8529411764
Buyback yield (%): 0
Retained earnings: 5373956.617647058
Inventory turnover: 0.8661253310164846
Receivables turnover: 14.966716311847124
Capitalized R&D asset: 670445.5882352941
ROCI (R&D-adjusted, %): 7.663259207289652
FCF margin (%): 21.455646610515693
Rule of 40 score: 21.455646610515693
Financial ratios for CMI.V — annual report dated 2023-11-30
Total revenue: 6099233.0882352935
Gross profit: 4214562.5
Operating income: 1124992.6470588234
Net income: 1230078.6764705882
Capital expenditures: 81560.29411764705
Operating cash flow: -1186281.6176470588
Depreciation & amortization: 34226.470588235294
Net tangible assets: 18768734.55882353
Owner earnings: 1182744.8529411764
Return on net tangible assets (%): 6.301676062572616
Capex to operating income (%): 7.249851306217687
Buffett classification: The Great
Stock price: 0.7058823529411764
P/E ratio: 24.248951077376088
Shares outstanding: 42256500
Book value: 18775322.79411765
P/B ratio: 1.588687341045558
Market cap (USD): 29828117.647058822
Debt to equity: 0
Current ratio: 29.61815091675422
Quick ratio: 19.723382687124268
Effective tax rate (%): 25.637175478017742
COGS to revenue (%): 30.90012401510942
R&D to revenue (%): 16.03610482851207
SG&A to revenue (%): 34.618949802874205
Free cash flow (dilution-adjusted): -1508036.0294117646
Buyback yield (%): 0
Retained earnings: 5064094.117647058
Inventory turnover: 0.28983591149119364
Receivables turnover: 3.9817730334403465
Capitalized R&D asset: 1427277.9558823528
ROCI (R&D-adjusted, %): 7.635226458133684
Rosenberg metric: -0.10552793028341548
FCF margin (%): -24.72501062995263
Revenue growth (%): -28.779908944276674
Rule of 40 score: -53.504919574229305
Financial ratios for CMI.V — quarterly report dated 2024-11-30
Total revenue: 967678.5714285715
Gross profit: -44914.28571428572
Operating income: -763121.4285714286
Net income: -387911.4285714286
Capital expenditures: 0
Operating cash flow: -269936.4285714286
Depreciation & amortization: 80336.42857142858
Net tangible assets: 16825955
Owner earnings: -307575
Return on net tangible assets (%): -1.8279794519835575
Buffett classification: The Gruesome
Stock price: 0.9214285714285715
Shares outstanding: 42256500
Book value: 16825955
P/B ratio: 2.3140645763388425
Market cap (USD): 38936346.42857143
Debt to equity: 0.06350524701697043
Current ratio: 20.741528305976804
Quick ratio: 14.793995875548886
Interest coverage ratio: -38.54565789948407
COGS to revenue (%): 104.64144676139509
R&D to revenue (%): 30.246170880236207
SG&A to revenue (%): 43.97342683151873
Free cash flow (dilution-adjusted): -328931.4285714286
Buyback yield (%): 0
Retained earnings: 3259906.4285714286
Inventory turnover: 0.19796368163879624
Receivables turnover: 0.9979595144086274
Capitalized R&D asset: 292685.7142857143
ROCI (R&D-adjusted, %): -3.0864610826043104
FCF margin (%): -33.99180660638494
Rule of 40 score: -33.99180660638494
Financial ratios for CMI.V — annual report dated 2024-11-30
Total revenue: 5633464.285714286
Gross profit: 2693916.4285714286
Operating income: -633831.4285714286
Net income: -151053.57142857145
Capital expenditures: 0
Operating cash flow: 1859605.0000000002
Depreciation & amortization: 108777.14285714287
Net tangible assets: 16825955
Owner earnings: -42276.42857142858
Return on net tangible assets (%): -0.25125723069762507
Buffett classification: The Gruesome
Stock price: 0.9214285714285715
Shares outstanding: 42256500
Book value: 16825955
P/B ratio: 2.3140645763388425
Market cap (USD): 38936346.42857143
Debt to equity: 0.06350524701697043
Current ratio: 20.741528305976804
Quick ratio: 14.793995875548886
Interest coverage ratio: -11.921807824591573
COGS to revenue (%): 52.180109929819885
R&D to revenue (%): 23.206527320793473
SG&A to revenue (%): 33.93363636939969
Free cash flow (dilution-adjusted): 1668664.285714286
Buyback yield (%): 0
Retained earnings: 3259906.4285714286
Inventory turnover: 0.5746867677848296
Receivables turnover: 5.809748659319936
Capitalized R&D asset: 2183891.6785714286
ROCI (R&D-adjusted, %): -1.536336899372275
Rosenberg metric: -1.55472659288977
FCF margin (%): 29.620570950379427
Revenue growth (%): -7.6365142270004505
Rule of 40 score: 21.984056723378977
Financial ratios for CMI.V — quarterly report dated 2025-02-28
Total revenue: 484978.47222222225
Gross profit: 212802.08333333334
Operating income: -605030.5555555556
Net income: -347813.19444444444
Capital expenditures: 93.75
Operating cash flow: -280583.3333333334
Depreciation & amortization: 4533.333333333334
Net tangible assets: 16020440.277777778
Owner earnings: -343373.6111111111
Return on net tangible assets (%): -2.1433469065604296
Buffett classification: The Gruesome
Stock price: 0.8333333333333334
Shares outstanding: 42256500
Book value: 16020440.277777778
P/B ratio: 2.1980513262700767
Market cap (USD): 35213750
Debt to equity: 0.06194803045449663
Current ratio: 20.648337511767664
Quick ratio: 14.694045815435798
Interest coverage ratio: -32.84243063932449
COGS to revenue (%): 56.12133413711089
R&D to revenue (%): 67.90994445629745
SG&A to revenue (%): 100.72282704415574
Free cash flow (dilution-adjusted): -291127.0833333334
Buyback yield (%): 0
Retained earnings: 2821540.277777778
Inventory turnover: 0.05552631590132048
Receivables turnover: 0.5002138036201215
Capitalized R&D asset: 525448.0396825398
ROCI (R&D-adjusted, %): -2.722474907849942
Rosenberg metric: 0.8805225416503969
FCF margin (%): -60.028867260717476
Revenue growth (%): -49.88227635275061
Rule of 40 score: -109.91114361346808
Financial ratios for CMI.V — quarterly report dated 2025-05-31
Total revenue: 1149732.6086956523
Gross profit: 630271.7391304348
Operating income: -162357.2463768116
Net income: -65840.57971014493
Capital expenditures: 0
Operating cash flow: 94661.59420289856
Depreciation & amortization: 5174.637681159421
Net tangible assets: 16668015.942028986
Owner earnings: -60665.942028985504
Return on net tangible assets (%): -0.3639661867374041
Buffett classification: The Gruesome
Stock price: 0.7753623188405798
Shares outstanding: 42256500
Book value: 16668015.942028988
P/B ratio: 1.9656867344043711
Market cap (USD): 32764097.82608696
Debt to equity: 0.05917134012889912
Current ratio: 26.78925747446673
Quick ratio: 19.426612811848063
Interest coverage ratio: -8.849903227080619
COGS to revenue (%): 45.181015623670525
R&D to revenue (%): 28.949768408659605
SG&A to revenue (%): 39.99052079532039
Free cash flow (dilution-adjusted): 77785.50724637682
Buyback yield (%): 0
Retained earnings: 2878374.6376811597
Inventory turnover: 0.10815834665844276
Receivables turnover: 1.1571686752260177
Capitalized R&D asset: 650094.7826949621
ROCI (R&D-adjusted, %): -0.7990665359711864
Rosenberg metric: 1.2675616101391765
FCF margin (%): 6.7655302335577705
Revenue growth (%): 137.06879264711625
Rule of 40 score: 143.83432288067402
Financial ratios for CMI.V — annual report dated 2025-11-30
Total revenue: 4130734.285714286
Gross profit: 2034192.142857143
Operating income: -787597.8571428572
Net income: -291107.1428571429
Capital expenditures: 96.42857142857143
Operating cash flow: -87237.14285714287
Depreciation & amortization: 245188.57142857145
Net tangible assets: 16668594.285714287
Owner earnings: -46015.00000000002
Return on net tangible assets (%): -0.2760580719121401
Buffett classification: The Gruesome
Stock price: 0.5857142857142857
Shares outstanding: 42256500
Book value: 16668594.285714285
P/B ratio: 1.484842410226383
Market cap (USD): 24750235.714285716
Debt to equity: 0.05229698005213569
Current ratio: 25.178363756394774
Quick ratio: 19.024763574898778
Interest coverage ratio: -5.582802547770701
COGS to revenue (%): 56.23014448486157
R&D to revenue (%): 25.01538986150508
SG&A to revenue (%): 37.36096384108809
Free cash flow (dilution-adjusted): -221865.71428571432
Buyback yield (%): 0
Retained earnings: 2968799.285714286
Inventory turnover: 0.5400317561700085
Receivables turnover: 2.511677964747209
Capitalized R&D asset: 2231997.5487394957
ROCI (R&D-adjusted, %): -4.298538010047718
Rosenberg metric: -0.5046343041222467
FCF margin (%): -5.371096249231372
Revenue growth (%): -26.675060385324944
Rule of 40 score: -32.04615663455632
Financial ratios for CMI.V — quarterly report dated 2025-11-30
Total revenue: 1117296.4285714286
Gross profit: 480389.28571428574
Operating income: -79749.28571428572
Net income: 20669.285714285717
Capital expenditures: 0
Operating cash flow: -17557.14285714286
Depreciation & amortization: 4625
Net tangible assets: 16668594.285714287
Owner earnings: 25294.285714285717
Return on net tangible assets (%): 0.15174816352668696
Buffett classification: The Gruesome
Stock price: 0.5857142857142857
P/E ratio: 299.3600753360749
Shares outstanding: 42256500
Book value: 16668594.285714285
P/B ratio: 1.484842410226383
Market cap (USD): 24750235.714285716
Debt to equity: 0.05229698005213569
Current ratio: 25.178363756394774
Quick ratio: 19.024763574898778
Effective tax rate (%): 85.51157842032795
Interest coverage ratio: -0.9183473711916826
COGS to revenue (%): 57.00431206707517
R&D to revenue (%): 7.8778812375536615
SG&A to revenue (%): 56.05776699494635
Free cash flow (dilution-adjusted): -84587.14285714286
Buyback yield (%): 0
Retained earnings: 2968799.285714286
Inventory turnover: 0.1480808707853366
Receivables turnover: 0.6793680313543451
Capitalized R&D asset: 419710.4288302278
ROCI (R&D-adjusted, %): -1.3280907849329453
Rosenberg metric: -0.45030715812796507
FCF margin (%): -7.570698401434585
Revenue growth (%): -2.821193369562847
Rule of 40 score: -10.391891770997432
Financial ratios for CRNX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.41
Shares outstanding: 105840233
Market cap (USD): 3006921019.53
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRNX — annual report dated 2022-12-31
Total revenue: 4737000
Operating income: -167882000
Net income: -163918000
Capital expenditures: 1656000
Operating cash flow: -115205000
Depreciation & amortization: 983000
Net tangible assets: 316328000
Owner earnings: -164591000
Return on net tangible assets (%): -52.031751852507526
Buffett classification: The Gruesome
Stock price: 18.3
Shares outstanding: 105840233
Book value: 316328000
P/B ratio: 6.122999746781821
Market cap (USD): 1936876263.9
Debt to equity: 0.009720922586682178
Current ratio: 12.451177722468708
Quick ratio: 12.451177722468708
COGS to revenue (%): 0
R&D to revenue (%): 2749.102807684188
SG&A to revenue (%): 894.9546126240236
Free cash flow (dilution-adjusted): -145129000
Buyback yield (%): 0
Retained earnings: -439173000
Receivables turnover: 1.5633663366336634
Capitalized R&D asset: 130225000
ROCI (R&D-adjusted, %): -17.829174346094014
FCF margin (%): -3063.732320033777
Rule of 40 score: -3063.732320033777
Financial ratios for CRNX — annual report dated 2023-12-31
Total revenue: 4013000
Gross profit: 4013000
Operating income: -222608000
Net income: -214529000
Capital expenditures: 4688000
Operating cash flow: -168598000
Depreciation & amortization: 1098000
Net tangible assets: 539106000
Owner earnings: -218119000
Return on net tangible assets (%): -40.45939017558699
Buffett classification: The Gruesome
Stock price: 35.58
Shares outstanding: 105840233
Book value: 539106000
P/B ratio: 6.9852598378426505
Market cap (USD): 3765795490.14
Debt to equity: 0.09595144554132211
Current ratio: 13.066155386646033
Quick ratio: 13.066155386646033
COGS to revenue (%): 0
R&D to revenue (%): 4199.526538749065
SG&A to revenue (%): 1447.6451532519313
Free cash flow (dilution-adjusted): -214223000
Buyback yield (%): 0.014366154546005032
Retained earnings: -653702000
Receivables turnover: 0.4291519623569672
Capitalized R&D asset: 255777750
ROCI (R&D-adjusted, %): -18.138224805275094
FCF margin (%): -5338.225766259656
Revenue growth (%): -15.283934979945112
Rule of 40 score: -5353.509701239601
Financial ratios for CRNX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.1
Shares outstanding: 105840233
Market cap (USD): 5408435906.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRNX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.13
Shares outstanding: 105840233
Market cap (USD): 5411611113.29
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRNX — annual report dated 2024-12-31
Total revenue: 1039000
Gross profit: 1039000
Operating income: -338854000
Net income: -298408000
Capital expenditures: 3844000
Operating cash flow: -230194000
Depreciation & amortization: 2785000
Net tangible assets: 1324805000
Owner earnings: -299467000
Return on net tangible assets (%): -22.604609735017604
Buffett classification: The Gruesome
Stock price: 51.13
Shares outstanding: 105840233
Book value: 1324805000
P/B ratio: 4.0848359670215615
Market cap (USD): 5411611113.29
Debt to equity: 0.039041217386709744
Current ratio: 23.04450103880437
Quick ratio: 23.04450103880437
COGS to revenue (%): 0
R&D to revenue (%): 23114.14821944177
SG&A to revenue (%): 9599.326275264677
Free cash flow (dilution-adjusted): -303424000
Buyback yield (%): 0.27684916167029716
Retained earnings: -952110000
Capitalized R&D asset: 396043340
ROCI (R&D-adjusted, %): -15.716637363960547
Rosenberg metric: -0.017647023919015944
FCF margin (%): -29203.46487006737
Revenue growth (%): -74.109145277847
Rule of 40 score: -29277.574015345217
Financial ratios for CRNX — quarterly report dated 2025-03-31
Total revenue: 361000
Gross profit: 361000
Operating income: -111405000
Net income: -96774000
Capital expenditures: 1239000
Operating cash flow: -88452000
Depreciation & amortization: 925000
Net tangible assets: 1254000000
Owner earnings: -97088000
Return on net tangible assets (%): -7.742264752791068
Buffett classification: The Gruesome
Stock price: 33.54
Shares outstanding: 105840233
Book value: 1254000000
P/B ratio: 2.8308464233014354
Market cap (USD): 3549881414.8199997
Debt to equity: 0.04052551834130781
Current ratio: 22.527176283784964
Quick ratio: 22.527176283784964
COGS to revenue (%): 0
R&D to revenue (%): 21119.1135734072
SG&A to revenue (%): 9840.997229916897
Free cash flow (dilution-adjusted): -110169000
Buyback yield (%): 0
Retained earnings: -1048884000
Receivables turnover: 0.049357396773311454
Capitalized R&D asset: 76240000
ROCI (R&D-adjusted, %): -4.388920123030317
FCF margin (%): -30517.728531855955
Rule of 40 score: -30517.728531855955
Financial ratios for CRNX — quarterly report dated 2025-06-30
Total revenue: 1031000
Operating income: -129112000
Net income: -115637000
Capital expenditures: 3202000
Operating cash flow: -85851000
Depreciation & amortization: 959000
Net tangible assets: 1171526000
Owner earnings: -117880000
Return on net tangible assets (%): -10.062089957883991
Buffett classification: The Gruesome
Stock price: 28.76
Shares outstanding: 105840233
Book value: 1171526000
P/B ratio: 2.5982906918668474
Market cap (USD): 3043965101.0800004
Debt to equity: 0.042624747551484134
Current ratio: 17.797298087607462
Quick ratio: 17.797298087607462
COGS to revenue (%): 0
R&D to revenue (%): 7788.651794374394
SG&A to revenue (%): 4834.335596508245
Free cash flow (dilution-adjusted): -115177000
Buyback yield (%): 0
Retained earnings: -1164521000
Capitalized R&D asset: 131381800
ROCI (R&D-adjusted, %): -7.466681571737778
FCF margin (%): -11171.387002909796
Revenue growth (%): 185.595567867036
Rule of 40 score: -10985.79143504276
Financial ratios for CRNX — quarterly report dated 2025-09-30
Total revenue: 143000
Operating income: -142586000
Net income: -130091000
Capital expenditures: 863000
Operating cash flow: -110718000
Depreciation & amortization: 1012000
Net tangible assets: 1072169000
Owner earnings: -129942000
Return on net tangible assets (%): -12.119544586720938
Buffett classification: The Gruesome
Stock price: 41.65
Shares outstanding: 105840233
Book value: 1072169000
P/B ratio: 4.1115213221516385
Market cap (USD): 4408245704.45
Debt to equity: 0.04583605756182094
Current ratio: 15.120693142741555
Quick ratio: 15.120693142741555
COGS to revenue (%): 0
R&D to revenue (%): 63261.53846153846
SG&A to revenue (%): 36548.95104895105
Free cash flow (dilution-adjusted): -134283000
Buyback yield (%): 0
Retained earnings: -1294612000
Capitalized R&D asset: 169424870
ROCI (R&D-adjusted, %): -10.41252299318903
FCF margin (%): -93904.19580419581
Revenue growth (%): -86.12997090203686
Rule of 40 score: -93990.32577509785
Financial ratios for CRNX — quarterly report dated 2025-12-31
Total revenue: 1000000
Operating income: -137751000
Net income: -122815000
Capital expenditures: 458000
Operating cash flow: -92901000
Depreciation & amortization: 994000
Net tangible assets: 992083000
Owner earnings: -122279000
Return on net tangible assets (%): -12.325480831744924
Buffett classification: The Gruesome
Stock price: 46.55
Shares outstanding: 105840233
Book value: 992083000
P/B ratio: 4.966180093953832
Market cap (USD): 4926862846.15
Debt to equity: 0.04892836587261348
Current ratio: 12.322996990784278
Quick ratio: 12.299228888470942
COGS to revenue (%): 0
R&D to revenue (%): 8505.3
SG&A to revenue (%): 5369.8
Free cash flow (dilution-adjusted): -115079000
Buyback yield (%): 0
Retained earnings: -1417427000
Inventory turnover: 0
Receivables turnover: 1.6891891891891893
Capitalized R&D asset: 172163210
ROCI (R&D-adjusted, %): -11.371069370652197
FCF margin (%): -11507.9
Revenue growth (%): 599.3006993006993
Rule of 40 score: -10908.599300699301
Financial ratios for CRNX — annual report dated 2025-12-31
Total revenue: 1249147.87
Gross profit: 1000000
Operating income: -137751000
Net income: -465317000
Capital expenditures: 5762000
Operating cash flow: -377922000
Depreciation & amortization: 3890000
Net tangible assets: 992083000
Owner earnings: -467189000
Return on net tangible assets (%): -47.0917251883159
Buffett classification: The Gruesome
Stock price: 46.55
Shares outstanding: 105840233
Book value: 992083000
P/B ratio: 4.966180093953832
Market cap (USD): 4926862846.15
Debt to equity: 0.04892836587261348
Current ratio: 12.322996990784278
Quick ratio: 12.299228888470942
COGS to revenue (%): 86.13872111073606
R&D to revenue (%): 26582.761574896653
SG&A to revenue (%): 15316.92160672699
Free cash flow (dilution-adjusted): -474708000
Buyback yield (%): 0
Retained earnings: -1417427000
Inventory turnover: 0.5321463897131553
Receivables turnover: 2.1100470777027027
Capitalized R&D asset: 548576430
ROCI (R&D-adjusted, %): -3.3090918973085572
Rosenberg metric: -0.00016239444361165243
FCF margin (%): -38002.54648795102
Revenue growth (%): 20.225974013474506
Rule of 40 score: -37982.32051393754
Financial ratios for CTMX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.33
Shares outstanding: 217702919
Market cap (USD): 942653639.27
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTMX — annual report dated 2022-12-31
Total revenue: 53163000
Operating income: -101335000
Net income: -99317000
Capital expenditures: 1740000
Operating cash flow: -110788000
Depreciation & amortization: 2443000
Net tangible assets: -87575000
Owner earnings: -98614000
Buffett classification: The Gruesome
Stock price: 1.6
Shares outstanding: 217702919
Book value: -85751000
Market cap (USD): 348324670.40000004
Debt to equity: -0.2105748037923756
Current ratio: 1.5536669113021597
Quick ratio: 1.5536669113021597
COGS to revenue (%): 0
R&D to revenue (%): 210.0126027500329
SG&A to revenue (%): 80.59928897917726
Free cash flow (dilution-adjusted): -125653000
Buyback yield (%): 0
Retained earnings: -722879000
Receivables turnover: 1.4773245150892014
Capitalized R&D asset: 111649000
ROCI (R&D-adjusted, %): -12.232114168621818
FCF margin (%): -236.3542313262984
Rule of 40 score: -236.3542313262984
Financial ratios for CTMX — annual report dated 2023-12-31
Total revenue: 101214000
Operating income: -6484000
Net income: -569000
Capital expenditures: 840000
Operating cash flow: -56035000
Depreciation & amortization: 2175000
Net tangible assets: -49125000
Owner earnings: 766000
Buffett classification: The Gruesome
Stock price: 1.55
Shares outstanding: 217702919
Book value: -47447000
Market cap (USD): 337439524.45
Debt to equity: -0.29451809387316374
Current ratio: 1.1733210187732903
Quick ratio: 1.1733210187732903
Effective tax rate (%): 117.12308155281373
COGS to revenue (%): 0
R&D to revenue (%): 76.74827593020729
SG&A to revenue (%): 29.657952457169955
Free cash flow (dilution-adjusted): -65433000
Buyback yield (%): 0
Retained earnings: -723448000
Receivables turnover: 29.49125874125874
Capitalized R&D asset: 152484830
ROCI (R&D-adjusted, %): 4.076516032854042
FCF margin (%): -64.64817120161243
Revenue growth (%): 90.3842898256306
Rule of 40 score: 25.736118624018175
Financial ratios for CTMX — quarterly report dated 2024-09-30
Capital expenditures: 19000
Buffett classification: The Gruesome
Stock price: 1.18
Shares outstanding: 217702919
Market cap (USD): 256889444.42
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTMX — annual report dated 2024-12-31
Total revenue: 138103000
Operating income: 24995000
Net income: 31869000
Capital expenditures: 310000
Operating cash flow: -86231000
Depreciation & amortization: 1768000
Net tangible assets: -1988000
Owner earnings: 33327000
Return on net tangible assets (%): -1676.4084507042253
Capex to operating income (%): 1.240248049609922
Buffett classification: The Great
Stock price: 1.03
P/E ratio: 7.036116808497286
Shares outstanding: 217702919
Book value: -456000
Market cap (USD): 224234006.57
Debt to equity: -20.58114035087719
Current ratio: 1.2510492934757262
Quick ratio: 1.2510492934757262
Effective tax rate (%): 0.6979715202692176
COGS to revenue (%): 0
R&D to revenue (%): 60.376675379970024
SG&A to revenue (%): 21.524514311781786
Free cash flow (dilution-adjusted): -94209000
Buyback yield (%): 0
Retained earnings: -691579000
Receivables turnover: 44.50628424105704
Capitalized R&D asset: 172271770
ROCI (R&D-adjusted, %): 8.439887720834403
FCF margin (%): -68.21647610841184
Revenue growth (%): 36.44653901634161
Rule of 40 score: -31.76993709207023
Financial ratios for CTMX — quarterly report dated 2024-12-31
Capital expenditures: 80000
Buffett classification: The Gruesome
Stock price: 1.03
Shares outstanding: 217702919
Market cap (USD): 224234006.57
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTMX — quarterly report dated 2025-03-31
Total revenue: 50917000
Operating income: 22621000
Net income: 23525000
Capital expenditures: 119000
Operating cash flow: -21043000
Depreciation & amortization: 385000
Net tangible assets: 23553000
Owner earnings: 23791000
Return on net tangible assets (%): 101.01048698679574
Capex to operating income (%): 0.5260598558861235
Buffett classification: The Great
Stock price: 0.64
P/E ratio: 1.4806574724760893
Shares outstanding: 217702919
Book value: 25049000
P/B ratio: 5.562292632839635
Market cap (USD): 139329868.16
Debt to equity: 0.32532236815840954
Current ratio: 1.7256229955578575
Quick ratio: 1.7256229955578575
Effective tax rate (%): 0.26285665832874044
COGS to revenue (%): 0
R&D to revenue (%): 37.05638588290748
SG&A to revenue (%): 18.51640905787851
Free cash flow (dilution-adjusted): -23170000
Buyback yield (%): 0
Retained earnings: -668054000
Receivables turnover: 26.03118609406953
Capitalized R&D asset: 18868000
ROCI (R&D-adjusted, %): 52.40853234867885
FCF margin (%): -45.505430406347585
Rule of 40 score: -45.505430406347585
Financial ratios for CTMX — quarterly report dated 2025-06-30
Total revenue: 18658000
Operating income: -1286000
Net income: -154000
Capital expenditures: 27000
Operating cash flow: -15753000
Depreciation & amortization: 347000
Net tangible assets: 118451000
Owner earnings: 166000
Buffett classification: The Gruesome
Stock price: 2.27
P/E ratio: 21.145249502802617
Shares outstanding: 217702919
Book value: 119910000
P/B ratio: 4.121304529480444
Market cap (USD): 494185626.13
Debt to equity: 0.05741806354766075
Current ratio: 4.197052749662188
Quick ratio: 4.197052749662188
COGS to revenue (%): 0
R&D to revenue (%): 71.40100761067639
SG&A to revenue (%): 35.49147818630078
Free cash flow (dilution-adjusted): -17211000
Buyback yield (%): 0
Retained earnings: -668208000
Receivables turnover: 9.982878544676298
Capitalized R&D asset: 25963560
ROCI (R&D-adjusted, %): 0.8071815174468638
FCF margin (%): -92.24461357058634
Revenue growth (%): -63.35605004222559
Rule of 40 score: -155.60066361281193
Financial ratios for CTMX — quarterly report dated 2025-09-30
Total revenue: 5963000
Operating income: -15768000
Net income: -14229000
Capital expenditures: 127000
Operating cash flow: -15548000
Depreciation & amortization: 134000
Net tangible assets: 105966000
Owner earnings: -14222000
Return on net tangible assets (%): -13.421286072891306
Buffett classification: The Gruesome
Stock price: 3.19
P/E ratio: 75.96503080398162
Shares outstanding: 217702919
Book value: 107389000
P/B ratio: 6.466884984588738
Market cap (USD): 694472311.61
Debt to equity: 0.052109620165938786
Current ratio: 3.636866606546589
Quick ratio: 3.636866606546589
COGS to revenue (%): 0
R&D to revenue (%): 256.64933758175414
SG&A to revenue (%): 107.78131812845884
Free cash flow (dilution-adjusted): -16805000
Buyback yield (%): 0
Retained earnings: -682437000
Receivables turnover: 3.6605279312461634
Capitalized R&D asset: 30456180
ROCI (R&D-adjusted, %): -11.034129963840575
FCF margin (%): -281.8212309240315
Revenue growth (%): -68.04051881230572
Rule of 40 score: -349.86174973633723